Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium phosphate cement (CPC) is a self-setting, injectable biomaterial primarily used for the treatment and restoration of bone defects. It is bioabsorbable and osteoconductive, meaning it supports new bone growth by acting as a scaffold that gradually resorbs and is replaced by natural bone tissue. CPCs are widely used in orthopedic, craniofacial, and dental applications due to their biocompatibility, moldability, and ability to harden in situ at body temperature. The mechanism of action involves the chemical setting reaction between calcium phosphate powders and an aqueous solution to form hydroxyapatite or other calcium phosphate phases similar to the mineral component of bone[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium phosphate cement.